The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde, Vaios Karanikas, Stefan Evers
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1158/1078-0432.ccr-15-1507
- Published
- Apr 14, 2016
- Venue
- Clinical Cancer Research
- DOI
- 10.1158/1078-0432.ccr-15-1507
- PubMed
- 27084740
- Categories
- Cancer Immunotherapy and Biomarkers
- Provenance
- openalex